These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11097522)

  • 21. Benefit on motor and non-motor behavior in a specialized unit for Parkinson's disease.
    Müller T; Öhm G; Eilert K; Möhr K; Rotter S; Haas T; Küchler M; Lütge S; Marg M; Rothe H
    J Neural Transm (Vienna); 2017 Jun; 124(6):715-720. PubMed ID: 28247031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative Motor Performance and Sleep Benefit in Parkinson Disease.
    van Gilst MM; van Mierlo P; Bloem BR; Overeem S
    Sleep; 2015 Oct; 38(10):1567-73. PubMed ID: 25902811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digitomotography in Parkinson's disease: a cross-sectional and longitudinal study.
    Maetzler W; Ellerbrock M; Heger T; Sass C; Berg D; Reilmann R
    PLoS One; 2015; 10(4):e0123914. PubMed ID: 25902182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
    Goetz CG; Stebbins GT; Blasucci LM
    Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender-related patterns of dysprosody in Parkinson disease and correlation between speech variables and motor symptoms.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Jan; 25(1):76-82. PubMed ID: 20381998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donors.
    Adler CH; Hentz JG; Joyce JN; Beach T; Caviness JN
    Parkinsonism Relat Disord; 2002 Dec; 9(2):103-10. PubMed ID: 12473400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A computer vision framework for finger-tapping evaluation in Parkinson's disease.
    Khan T; Nyholm D; Westin J; Dougherty M
    Artif Intell Med; 2014 Jan; 60(1):27-40. PubMed ID: 24332155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of computer-key-hold-time and alternating-finger-tapping tests for early-stage Parkinson's disease.
    Lan BL; Yeo JHW
    PLoS One; 2019; 14(6):e0219114. PubMed ID: 31247037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bradykinesia akinesia inco-ordination test (BRAIN TEST): an objective computerised assessment of upper limb motor function.
    Giovannoni G; van Schalkwyk J; Fritz VU; Lees AJ
    J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):624-9. PubMed ID: 10519869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An objective measure combining physical and cognitive fatigability: Correlation with subjective fatigue in Parkinson's disease.
    Martino D; Tamburini T; Zis P; Rosoklija G; Abbruzzese G; Ray-Chaudhuri K; Pelosin E; Avanzino L
    Parkinsonism Relat Disord; 2016 Nov; 32():80-86. PubMed ID: 27600158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hand rhythmic tapping and timing in Parkinson's disease.
    Yahalom G; Simon ES; Thorne R; Peretz C; Giladi N
    Parkinsonism Relat Disord; 2004 Mar; 10(3):143-8. PubMed ID: 15036168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET.
    Pal PK; Lee CS; Samii A; Schulzer M; Stoessl AJ; Mak EK; Wudel J; Dobko T; Tsui JK
    Parkinsonism Relat Disord; 2001 Oct; 7(4):305-309. PubMed ID: 11344014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smartphone-based tactile cueing improves motor performance in Parkinson's disease.
    Ivkovic V; Fisher S; Paloski WH
    Parkinsonism Relat Disord; 2016 Jan; 22():42-7. PubMed ID: 26589004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori infection is associated with worse severity of Parkinson's disease.
    Tan AH; Mahadeva S; Marras C; Thalha AM; Kiew CK; Yeat CM; Ng SW; Ang SP; Chow SK; Loke MF; Vadivelu JS; Ibrahim N; Yong HS; Tan CT; Fox SH; Lang AE; Lim SY
    Parkinsonism Relat Disord; 2015 Mar; 21(3):221-5. PubMed ID: 25560322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predictive ocular motor control in Parkinson's disease].
    Ying L; Liu ZG; Chen W; Gan J; Wang WA
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):442-4. PubMed ID: 18642781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leap motion evaluation for assessment of upper limb motor skills in Parkinson's disease.
    Butt AH; Rovini E; Dolciotti C; Bongioanni P; De Petris G; Cavallo F
    IEEE Int Conf Rehabil Robot; 2017 Jul; 2017():116-121. PubMed ID: 28813804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment benefit and daily drug costs associated with treating Parkinson's disease in a Parkinson's disease clinic.
    Müller T; Voss B; Hellwig K; Josef Stein F; Schulte T; Przuntek H
    CNS Drugs; 2004; 18(2):105-11. PubMed ID: 14728057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypometria in Parkinson's disease: automatic versus controlled processing.
    Oliveira RM; Gurd JM; Nixon P; Marshall JC; Passingham RE
    Mov Disord; 1998 May; 13(3):422-7. PubMed ID: 9613732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foot-tapping rate as an objective outcome measure for Parkinson disease clinical trials.
    Gunzler SA; Pavel M; Koudelka C; Carlson NE; Nutt JG
    Clin Neuropharmacol; 2009; 32(2):97-102. PubMed ID: 18978495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portable objective assessment of upper extremity motor function in Parkinson's disease.
    Chahine LM; Uribe L; Hogarth P; McNames J; Siderowf A; Marek K; Jennings D
    Parkinsonism Relat Disord; 2017 Oct; 43():61-66. PubMed ID: 28747279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.